Biologicals
Ended Purchase Order Awarded
- Contract number
- 75D30121P12794
- Awardee
-
Wuxi Advanced Therapies Inc. UEI DFL9LER9JCD9
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $103,000
Award facts
- Opportunity
-
- 75D30121Q74175 Solicitation number
- Contract value 100% obligated
- $103,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Atlanta, GA 30329, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Wuxi Advanced Therapies Inc., a for-profit organization, for $103,000.00 for biologicals. The contract is for work performed in Atlanta, GA and has an end date of April 30, 2022. This contract award does not have a set-aside designation.
Quick answers
Who was awarded contract 75D30121P12794?
75D30121P12794 was awarded to Wuxi Advanced Therapies Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 21, 2021.
How much is contract 75D30121P12794 worth?
The government has obligated $103,000 on 75D30121P12794.
Was contract 75D30121P12794 competed?
The extent of competition for 75D30121P12794 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award